Elevate your quality management practices with a comprehensive self-assessment tool designed to embed risk-based thinking across pharmaceutical and medical device organisations. This structured programme delivers the rigour of a multi-session consultancy engagement, empowering teams to proactively identify, assess and manage risk throughout the product lifecycle—ensuring compliance, enhancing decision-making and strengthening regulatory readiness.
Explore three critical pillars of risk integration:
- Module 1: Risk Governance in Regulated Environments
Establish a robust governance framework aligned with ISO 14971, ISO 9001:2015 and ICH Q9. Define risk appetite, assign clear ownership across functions, and meet stringent requirements from FDA 21 CFR Part 820 and EU MDR Article 10. Develop escalation pathways, document acceptance criteria, and institute regular reviews to maintain accuracy and accountability. - Module 2: Risk-Based Supplier Classification
Optimise vendor oversight by categorising suppliers according to criticality. Apply failure mode scoring, mandate risk documentation for high-risk partners, and tailor audit frequency and inspection protocols. Integrate supplier risk data into enterprise dashboards and enforce contractual risk controls to safeguard supply chain integrity. - Module 3: Risk Integration in Design & Development
Embed risk analysis at the earliest stages with Design Failure Mode and Effects Analysis (DFMEA). Link design inputs directly to risk controls within the Design History File, ensuring product safety and regulatory traceability. Align change control processes with risk re-evaluation to maintain design assurance.
Through practical frameworks and actionable methodologies, this self-assessment enables quality, compliance and operations leaders to build resilient, proactive systems that reduce non-conformances, accelerate approvals and support continuous improvement.
Take control of quality risk today—download the self-assessment and strengthen your organisation’s risk maturity.